Serotonin Syndrome :: Serotonin syndrome Symptoms
Symptoms may be classed into three groups:
Symptoms may be classed into three groups:
The first symptom to develop is usually muscular rigidity, followed by high fever and changes in cognitive functions.
Although treatment is not always necessary, it will help to cure the disease and prevent fatal developments from occurring. The first step in treatment is generally to remove the patient from any neuroleptic or antipsychotic drugs being taken and to treat fever aggressively.
Supportive care is treatment to manage symptoms and help patients live with a disease. Supportive care does not cure the disease. Supportive care treatments for boys with bleeding problems (thrombocytopenia) may include:
A comprehensive guide to the diagnosis and treatment of chronic fatigue syndrome and fibromyalgia vital help for the millions of people suffering from pain, fatigue, and sleep problems.
Adapted to bilious, lymphatic, plethoric constitutions; persons who are lively and entertaining when well, but violent and often delirious when sick.
Persons of a melancholy temperament, dark eyes, and a disposition to low spirits and indolence. Women of choleric temperament, with freckles and red hair (Phos.).
Neurogenic bladder is a condition in which the nerves of the urinary system don?t work properly when the bladder is full. It can lead to different kinds of problems, including urine leakage if the muscles holding urine do not get the right message. For some, the muscles don?t get the message the bladder is full and its time to let go. If the bladder becomes too full, urine may back up into the kidneys, and the extra pressure causes damage to the tiny blood vessels in the kidney. Urine that stays too long may also cause an infection of the bladder or ureters.
The Food and Drug Administration (FDA) announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck (SCCHN) that can not be removed by surgery (unresectable SCCHN). This is the first drug approved for head and neck cancer that has shown a survival benefit in this population. Erbitux was also approved today for use alone (monotherapy) to treat patients whose head and neck cancer has spread (metastasized) despite the use of standard chemotherapy.
Children with an early version of the cochlear implant face an increased risk of bacterial meningitis beyond just the first two years following implantation of the hearing devices, the Food and Drug Administration warned.